Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dube syndrome

被引:27
作者
Furuya, Mitsuko [1 ]
Hong, Seung-Beom [2 ]
Tanaka, Reiko [3 ]
Kuroda, Naoto [4 ]
Nagashima, Yoji [5 ]
Nagahama, Kiyotaka [6 ]
Suyama, Takahito [7 ]
Yao, Masahiro [8 ]
Nakatani, Yukio [9 ]
机构
[1] Yokohama City Univ, Dept Mol Pathol, Grad Sch Med, Yokohama, Kanagawa 2360004, Japan
[2] ISU Abxis, Sungnam, Nepal
[3] Chiba Univ, Med Mycol Res Ctr, Chiba, Japan
[4] Kochi Red Cross Hosp, Dept Pathol, Kochi, Japan
[5] Tokyo Womens Med Univ, Dept Surg Pathol, Tokyo, Japan
[6] Nippon Med Sch, Dept Anat Pathol, Tokyo 113, Japan
[7] Chiba Univ, Dept Urol, Grad Sch Med, Chiba, Japan
[8] Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa 2360004, Japan
[9] Chiba Univ, Grad Sch Med, Dept Diagnost Pathol, Chiba, Japan
来源
CANCER SCIENCE | 2015年 / 106卷 / 03期
基金
日本学术振兴会;
关键词
Birt-Hogg-Dube syndrome (BHD); familial cancer; folliculin (FLCN); glycoprotein non-metastatic B (GPNMB); renal tumor; INDUCED PATHWAY MEMBERS; IMMUNOEXPRESSION STATUS; PROGNOSTIC VALUE; CELL CARCINOMAS; BHD; GENE; MUTATIONS; FAMILIES; KIDNEY; PNEUMOTHORAX;
D O I
10.1111/cas.12601
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Birt-Hogg-Dube syndrome (BHD) is an inherited disorder associated with a germline mutation of the folliculin gene (FLCN). The affected families have a high risk for developing multiple renal cell carcinomas (RCC). Diagnostic markers that distinguish between FLCN-related RCC and sporadic RCC have not been investigated, and many patients with undiagnosed BHD fail to receive proper medical care. We investigated the histopathology of 27 RCCs obtained from 18 BHD patients who were diagnosed by genetic testing. Possible somatic mutations of RCC lesions were investigated by DNA sequencing. Western blotting and immunohistochemical staining were used to compare the expression levels of FLCN and glycoprotein non-metastatic B (GPNMB) between FLCN-related RCCs and sporadic renal tumors (n=62). The expression of GPNMB was also evaluated by quantitative RT-PCR. Histopathological analysis revealed that the most frequent histological type was chromophobe RCC (n=12), followed by hybrid oncocytic/chromophobe tumor (n=6). Somatic mutation analysis revealed small intragenic mutations in six cases and loss of heterozygosity in two cases. Western blot and immunostaining analyses revealed that FLCN-related RCCs showed overexpression of GPNMB and underexpression of FLCN, whereas sporadic tumors showed inverted patterns. GPNMBmRNA in FLCN-related RCCs was 23-fold more abundant than in sporadic tumors. The distinctive expression patterns of GPNMB and FLCN might identify patients with RCCs who need further work-up for BHD.
引用
收藏
页码:315 / 323
页数:9
相关论文
共 31 条
  • [1] Adley BP, 2006, ARCH PATHOL LAB MED, V130, P1865
  • [2] Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling
    Baba, Masaya
    Hong, Seung-Beom
    Sharma, Nirmala
    Warren, Michelle B.
    Nickerson, Michael L.
    Iwamatsu, Akihiro
    Esposito, Dominic
    Gillette, William K.
    Hopkins, Ralph F., III
    Hartley, James L.
    Furihata, Mutsuo
    Oishi, Shinya
    Zhen, Wei
    Burke, Terrence R., Jr.
    Linehan, W. Marston
    Schmidt, Laura S.
    Zbar, Berton
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (42) : 15552 - 15557
  • [3] Loss of the Birt-Hogg-Dube tumor suppressor results in apoptotic resistance due to aberrant TGFβ-mediated transcription
    Cash, T. P.
    Gruber, J. J.
    Hartman, T. R.
    Henske, E. P.
    Simon, M. C.
    [J]. ONCOGENE, 2011, 30 (22) : 2534 - 2546
  • [4] Immunoexpression status and prognostic value of mammalian target of rapamycin and hypoxia-induced pathway members in papillary cell renal cell carcinomas
    Chaux, Alcides
    Schultz, Luciana
    Albadine, Roula
    Hicks, Jessica
    Kim, Jenny J.
    Allaf, Mohamad E.
    Carducci, Michael A.
    Rodriguez, Ronald
    Hammers, Hans-Joerg
    Argani, Pedram
    Reuter, Victor E.
    Netto, George J.
    [J]. HUMAN PATHOLOGY, 2012, 43 (12) : 2129 - 2137
  • [5] Hybrid tumour 'oncocytoma-chromophobe renal cell carcinoma' of the kidney: a report of seven sporadic cases
    Delongchamps, Nicolas B.
    Galmiche, Louise
    Eiss, David
    Rouach, Yannick
    Vogt, Benoit
    Timsit, Marc-Olivier
    Vieillefond, Annick
    Mejean, Arnaud
    [J]. BJU INTERNATIONAL, 2009, 103 (10) : 1381 - 1384
  • [6] Pulmonary Cysts of Birt-Hogg-Dube Syndrome: A Clinicopathologic and Immunohistochemical Study of 9 Families
    Furuya, Mitsuko
    Tanaka, Reiko
    Koga, Shunsuke
    Yatabe, Yasushi
    Gotoda, Hiroko
    Takagi, Seiji
    Hsu, Yung-Hsiang
    Fujii, Takeshi
    Okada, Akira
    Kuroda, Naoto
    Moritani, Suzuko
    Mizuno, Hideki
    Nagashima, Yoji
    Nagahama, Kiyotaka
    Hiroshima, Kenzo
    Yoshino, Ichiro
    Nomura, Fumio
    Aoki, Ichiro
    Nakatani, Yukio
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (04) : 589 - 600
  • [7] Mutations in BHD and TP53 genes, but not in HNF1β gene, in a large series of sporadic chromophobe renal cell carcinoma
    Gad, S.
    Lefevre, S. H.
    Khoo, S. K.
    Giraud, S.
    Vieillefond, A.
    Vasiliu, V.
    Ferlicot, S.
    Molinie, V.
    Denoux, Y.
    Thiounn, N.
    Chretien, Y.
    Mejean, A.
    Zerbib, M.
    Benoit, G.
    Herve, J. M.
    Allegre, G.
    Bressac-de Paillerets, B.
    Teh, B. T.
    Richard, S.
    [J]. BRITISH JOURNAL OF CANCER, 2007, 96 (02) : 336 - 340
  • [8] Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2
    Hasumi, Yukiko
    Baba, Masaya
    Ajima, Rieko
    Hasumi, Hisashi
    Valera, Vladimir A.
    Klein, Mara E.
    Haines, Diana C.
    Merino, Maria J.
    Hong, Seung-Beom
    Yamaguchi, Terry P.
    Schmidt, Laura S.
    Linehan, W. Marston
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (44) : 18722 - 18727
  • [9] Hes O, 2013, HISTOL HISTOPATHOL, V28, P1257, DOI 10.14670/HH-28.1257
  • [10] Inactivation of the FLCN Tumor Suppressor Gene Induces TFE3 Transcriptional Activity by Increasing Its Nuclear Localization
    Hong, Seung-Beom
    Oh, HyoungBin
    Valera, Vladimir A.
    Baba, Masaya
    Schmidt, Laura S.
    Linehan, W. Marston
    [J]. PLOS ONE, 2010, 5 (12):